Metlife Target Price

Analysts' average 12-month price target for Metlife is $96.

Get informed when a big investor buys or sells

+ Follow

Share Price

$97.47

Average Target Price

$96.42

1.1% downside

12 analysts in the last 4 months

High: $105 | Low: $86

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-06	Barclays	$97	0.5% downside
2026-07-15	Atlantic Equities	$103	5.7% upside
2026-07-10	JefferiesSuneet Kamath	$103	5.7% upside
2026-07-08	UBSMichael Ward	$105	7.7% upside
2026-07-07	BarclaysAlex Scott	$94	3.6% downside
2026-07-06	Morgan Stanley	$103	5.7% upside
2026-06-24	Piper Sandler	$90	7.7% downside
2026-05-26	Piper Sandler	$86	11.8% downside
2026-05-21	Morgan StanleyBob Huang	$93	4.6% downside
2026-05-12	Wells Fargo	$95	2.5% downside
2026-05-08	Mizuho SecuritiesYaron Kinar	$95	2.5% downside
2026-05-07	BarclaysAlex Scott	$93	4.6% downside
2026-04-13	Mizuho SecuritiesYaron Kinar	$93	4.6% downside
2026-04-09	Evercore ISI	$96	1.5% downside
2026-04-09	UBS	$102	4.6% upside
2026-02-12	Mizuho Securities	$100	2.6% upside
2026-02-10	Evercore ISIThomas Gallagher	$95	2.5% downside
2026-02-05	UBS	$98	0.5% upside
2026-01-14	Mizuho Securities	$102	4.6% upside
2026-01-13	Wells FargoElyse Greenspan	$97	0.5% downside
2026-01-08	UBS	$94	3.6% downside
2026-01-08	Barclays	$90	7.7% downside
2026-01-06	Evercore ISI	$97	0.5% downside
2025-12-15	Mizuho Securities	$101	3.6% upside
2025-12-15	Morgan Stanley	$101	3.6% upside
2025-10-08	Barclays	$98	0.5% upside
2025-10-07	Morgan StanleyBob Huang	$97	0.5% downside
2025-09-19	Piper SandlerJohn Barnidge	$84	13.8% downside
2025-09-15	Wolfe ResearchTracy Benguigui	$95	2.5% downside
2025-07-14	Morgan StanleyBob Huang	$98	0.5% upside
2025-04-02	Piper SandlerJohn Barnidge	$94	3.6% downside
2025-02-28	Morgan Stanley	$109	11.8% upside
2024-10-02	Piper SandlerJohn Barnidge	$92	5.6% downside
2024-09-04	BarclaysAlex Scott	$91	6.6% downside
2024-08-01	Bank of America SecuritiesJoshua Shanker	$96	1.5% downside
2024-07-10	Morgan StanleyBob Huang	$83	14.8% downside
2024-05-22	Argus ResearchKevin Heal	$80	17.9% downside
2024-05-06	Piper SandlerJohn Barnidge	$82	15.9% downside
2024-03-13	CFRACatherine Seifert	$77	21% downside
2024-01-08	Goldman SachsAlex Scott	$80	17.9% downside
2023-09-14	Mizuho SecuritiesBrett Linzey	$145	48.8% upside
2023-02-02	Morgan Stanley	$90	7.7% downside
2023-01-10	Morgan Stanley	$88	9.7% downside
2023-01-09	Goldman Sachs	$78	20% downside
2023-01-06	J.P. Morgan	$80	17.9% downside
2022-12-09	Jefferies	$82	15.9% downside
2022-11-17	Morgan Stanley	$87	10.7% downside
2022-08-22	Credit Suisse	$77	21% downside
2022-08-17	Morgan Stanley	$83	14.8% downside
2022-08-04	Morgan Stanley	$79	18.9% downside

Metlife (MET) FAQ

Metlife's target price stands at $96. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $96 for MET implies 1.1% downside versus today's price ($97.47). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Metlife's target price evolved across reporting periods, while the comparison chart places MET next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Finance, target price is commonly used to spot outliers. Metlife's reading of $96 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.